Pam2CSK4-adjuvanted SARS-CoV-2 RBD nanoparticle vaccine induces robust humoral and cellular immune responses.
Qiao Y, Zhan Y, Zhang Y, Deng J, Chen A, Liu B, Zhang Y, Pan T, Zhang W, Zhang H, He X.
Qiao Y, et al. Among authors: zhang w, zhang h, zhang y.
Front Immunol. 2022 Dec 9;13:992062. doi: 10.3389/fimmu.2022.992062. eCollection 2022.
Front Immunol. 2022.
PMID: 36569949
Free PMC article.